However, manipulations in their function or abundance in the healthy hematologic system may result in fatal changes in this tissue compartment.147 Accordingly, this may indicate that in non-hematologic malignancies Bcl-2-targeting strategies should be used with specific caution concerning the functionality and homeostasis of the hematologic system. This evidence concerns the gene BCL2 and hematologic disorder.